Your browser doesn't support javascript.
loading
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.
Álvarez-Varela, Adrián; Novellasdemunt, Laura; Barriga, Francisco M; Hernando-Momblona, Xavier; Cañellas-Socias, Adrià; Cano-Crespo, Sara; Sevillano, Marta; Cortina, Carme; Stork, Diana; Morral, Clara; Turon, Gemma; Slebe, Felipe; Jiménez-Gracia, Laura; Caratù, Ginevra; Jung, Peter; Stassi, Giorgio; Heyn, Holger; Tauriello, Daniele V F; Mateo, Lidia; Tejpar, Sabine; Sancho, Elena; Stephan-Otto Attolini, Camille; Batlle, Eduard.
Afiliación
  • Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Novellasdemunt L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Barriga FM; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Cañellas-Socias A; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cano-Crespo S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Sevillano M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Cortina C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Stork D; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Morral C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Turon G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Slebe F; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Jiménez-Gracia L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Caratù G; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Jung P; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Stassi G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Heyn H; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Tauriello DVF; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Mateo L; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Tejpar S; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Sancho E; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stephan-Otto Attolini C; German Cancer Consortium (DKTK), Partner site Munich, Institute of Pathology, Ludwig Maximilian University, Munich, Germany.
  • Batlle E; Department of Surgical Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy.
Nat Cancer ; 3(9): 1052-1070, 2022 09.
Article en En | MEDLINE | ID: mdl-35773527
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Organoides Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Organoides Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: España